Skip to main content
. 2019 Nov 13;13(1):17–24. doi: 10.1016/j.tranon.2019.09.003

Figure 4.

Figure 4

TILs expressing CD39 and PD-1 and relapse of NSCLC. (A) Fractions of tumor-infiltrating CD4+ T cells coexpressing CD39 and PD1 correlated significantly with clinical stage in patients with NSCLC. A trend towards correlation was found in fractions of tumor-infiltrating CD8+ T cells coexpressing CD39 and PD1. (B) Spearman's rank correlation test was used to determine correlation. TILs: Tumor-infiltrating lymphocytes. Patients with relapse of NSCLC within the first 12 months after surgery are displayed in red points.